|
Post by mssciguy on Dec 21, 2015 7:51:51 GMT -5
chuck ... only problem is, no intelligent money would believe SNY is ditching Afrezza. There may still be downside based on that FUD, but they don't have an exit strategy based on something that isn't going to happen. The company is acting with the secrecy of the Google X labs or Apple labs. But, there is a problem with that: Google and Apple have tens of billions of dollars in the bank to get everything perfect prior to release. We do not. New CEO needs to know how to talk, how to deal.
|
|
|
Post by longstocking on Dec 21, 2015 13:56:52 GMT -5
chuck ... only problem is, no intelligent money would believe SNY is ditching Afrezza. There may still be downside based on that FUD, but they don't have an exit strategy based on something that isn't going to happen. The company is acting with the secrecy of the Google X labs or Apple labs. But, there is a problem with that: Google and Apple have tens of billions of dollars in the bank to get everything perfect prior to release. We do not. New CEO needs to know how to talk, how to deal. "acting with the secrecy of the Google X labs...." Maybe they are. DXCM/GOOG/SNY/MNKD Not too difficult to come up with a theory that connects these dots. Google partnered with SNY, in part, because of SNY's inhalable insulin, (see NPR article). Who's inhalable insulin?
|
|
|
Post by suebeeee1 on Dec 21, 2015 14:12:12 GMT -5
Connect the dots??? Really? We weren't even mentioned in Sanofi's year end newsletter. {SIGH} All I want for Christmas is some NEWS!!!
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Dec 21, 2015 14:21:36 GMT -5
Connect the dots??? Really? We weren't even mentioned in Sanofi's year end newsletter. {SIGH} All I want for Christmas is some NEWS!!! Be a little more patient, good news should be delivered during January and February.
|
|
|
Post by mssciguy on Dec 21, 2015 14:31:40 GMT -5
Connect the dots??? Really? We weren't even mentioned in Sanofi's year end newsletter. {SIGH} All I want for Christmas is some NEWS!!! Be a little more patient, good news should be delivered during January and February. Yes, it should, @kastanes But it also should have been in June, July, August, September, October, November, and even now Still waiting for that "inflection point" Where are the mgmt loyalties here? Not with retail shareholders. Not even close. 1. Overlord Sanofi, 2. Analysts/institutions Merry XMas and Happy Chanukah to all of Mannkind and you're welcome.
|
|